These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 2273595

  • 1. [Effect of methylprednisolone pulse therapy in patients with lupus nephritis assessed by WHO morphologic classification].
    Makino H, Yamasaki Y, Hayashi Y, Haramoto T, Shikata K, Kumagai I, Taniai K, Takahashi K, Ota Z.
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):791-9. PubMed ID: 2273595
    [Abstract] [Full Text] [Related]

  • 2. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S, Bogić M, Perić-Popadić A, Stefanović L, Arandjelović S, Jovicić Z, Bolpacić J, Tomić-Spirić V.
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
    [Abstract] [Full Text] [Related]

  • 3. [Double blind trial of pulse methylprednisolone versus conventional oral prednisolone in lupus nephritis].
    Honma M, Ichikawa Y, Akizuki M, Kashiwazaki S, Kondo H, Hashimoto H, Sugawara M, Hanaoka K.
    Ryumachi; 1994 Jun; 34(3):616-27. PubMed ID: 8052927
    [Abstract] [Full Text] [Related]

  • 4. Predictive factors of clinical outcome in patients with diffuse proliferative lupus nephritis treated early by intravenous methylprednisolone pulse therapy.
    Kanno A, Hotta O, Yusa N, Taguma Y.
    Ren Fail; 2007 Jun; 29(1):41-7. PubMed ID: 17365909
    [Abstract] [Full Text] [Related]

  • 5. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [Abstract] [Full Text] [Related]

  • 6. Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens.
    Mok CC, Ho CT, Siu YP, Chan KW, Kwan TH, Lau CS, Wong RW, Au TC.
    Am J Kidney Dis; 2001 Aug; 38(2):256-64. PubMed ID: 11479150
    [Abstract] [Full Text] [Related]

  • 7. The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment.
    Kim YG, Kim HW, Cho YM, Oh JS, Nah SS, Lee CK, Yoo B.
    Rheumatology (Oxford); 2008 Mar; 47(3):311-4. PubMed ID: 18204087
    [Abstract] [Full Text] [Related]

  • 8. [Methylprednisolone pulse therapy in the early phases of lupus nephritis].
    Mitić I, Fele D, Lenert P, Curić S, Vodopivec S, Bozić D, Sakac V, Djisalov M, Ilić T, Sebić L, Djurdjević-Mirković T, Tepavcević P.
    Srp Arh Celok Lek; 1996 Mar; 124 Suppl 1():67-9. PubMed ID: 9102936
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
    Valeri A, Radhakrishnan J, Estes D, D'Agati V, Kopelman R, Pernis A, Flis R, Pirani C, Appel GB.
    Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
    [Abstract] [Full Text] [Related]

  • 11. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Szeto CC, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, Gang W, Li PK.
    Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of necrosis in lupus nephritis.
    Makino H, Hayashi Y, Yamasaki Y, Shikata K, Kashihara N, Kira S, Ota Z.
    Intern Med; 1994 Aug; 33(8):461-5. PubMed ID: 7803911
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of serum C3 and CH50 levels as markers of disease-activity and indicators of efficacy of treatment of lupus nephritis in childhood].
    Ibe M, Kuriyama T, Mori M, Mitsuda T, Aihara Y, Yokota S.
    Ryumachi; 1994 Aug; 34(4):715-24. PubMed ID: 7974022
    [Abstract] [Full Text] [Related]

  • 14. [The use of ultrahigh doses of corticosteroids in treating the most severe variants of lupus nephritis].
    Ianushkevich TN, Klepikov PV.
    Ter Arkh; 1990 Aug; 62(6):50-3. PubMed ID: 2218927
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [Abstract] [Full Text] [Related]

  • 16. [Morphologic transformation of renal lesions by steroid treatment and its therapeutic implication in a patient with lupus nephritis].
    Saito M, Nakabayashi K, Maemura C, Kitamoto K, Nagasawa T.
    Ryumachi; 1990 Jun; 30(3):190-5; discussion 195-7. PubMed ID: 2244253
    [Abstract] [Full Text] [Related]

  • 17. Combination of immunoadsorption therapy and high-dose methylprednisolone in patients with lupus nephritis; possible indications in patients with early stage.
    Funauchi M, Ikoma S, Imada A, Kanamaru A.
    J Clin Lab Immunol; 1997 Jun; 49(2):47-57. PubMed ID: 9819673
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the effects of intravenous methylprednisolone pulse versus oral prednisolone therapies on the first attack of minimal-change nephrotic syndrome in adults.
    Fukudome K, Fujimoto S, Sato Y, Kitamura K.
    Nephrology (Carlton); 2012 Mar; 17(3):263-8. PubMed ID: 22117558
    [Abstract] [Full Text] [Related]

  • 19. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R, Greco S, Ponticelli C.
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [Abstract] [Full Text] [Related]

  • 20. Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis.
    Demircin G, Oner A, Erdoğan O, Delibaş A, Baysun S, Bülbül M, Bek K, Oksal A.
    Ren Fail; 2008 Sep; 30(6):603-9. PubMed ID: 18661410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.